Allogene Therapeutics, Inc
Allogene Therapeutics, Inc., based in South San Francisco, CA, is a pioneering biotechnology company focused on developing innovative allogeneic CAR T-cell therapies for the treatment of blood cancers, solid tumors, and autoimmune diseases. Their proprietary AlloCART product platform leverages advanced multiplex gene engineering and state-of-the-art manufacturing techniques to optimize treatment efficacy and accessibility.
The company is currently enrolling participants in the ALPHA3 trial, the industry's first pivotal Phase 2 first-line consolidation trial for an investigational allogeneic CAR T therapy in large B-cell lymphoma. With a highly experienced management team, Allogene is dedicated to leading the next revolution in cell therapy, aiming to deliver scalable and efficient treatment options to patients.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.